Healthcare Professionals

• About DUROLANE
• Classification
• Clinical data
• Benefits of DUROLANE
• Treatment
  • Clinical Procedure
  • Post Treatment
• Algorithms
• Resources
  • Enquiry Form

About DUROLANE

DUROLANE is a hyaluronic acid treatment for osteoarthritis of the knee and hip, based upon NASHA technology (Non Animal Stabilised Hyaluronic Acid).

DUROLANE is the only non-animal HA treatment currently available that can provide up to 6 months pain relief with a single injection¹.

The principle advantage of DUROLANE is NASHA, which dramatically increases the intra-articular residence time², therefore reducing the number of injections per course of treatment.

DUROLANE is an incredibly safe treatment; NASHA™ gels have been used for over 20 years in the health and beauty industry with few reactions. NASHA^™ gels are contained in the only hyaluronic acid derived products that have been safely used in paediatric medicine³.

> Classification

References

Ref 1: Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol. 2004;22:300-306

Ref 2: Lindqvist U, Tolmachev V, Kairemo K, Astrom G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41:603-613.

Ref 3: http://www.q-med.com/